Outcomes of very preterm infants with neonatal hyperglycaemia: a systematic review and meta-analysis.
endocrinology
mortality
neonatology
Journal
Archives of disease in childhood. Fetal and neonatal edition
ISSN: 1468-2052
Titre abrégé: Arch Dis Child Fetal Neonatal Ed
Pays: England
ID NLM: 9501297
Informations de publication
Date de publication:
May 2022
May 2022
Historique:
received:
17
12
2020
accepted:
15
07
2021
pubmed:
1
8
2021
medline:
23
4
2022
entrez:
31
7
2021
Statut:
ppublish
Résumé
To explore the association between hyperglycaemia and adverse outcomes in very preterm infants. Systematic review and meta-analysis. Data were pooled separately for adjusted and unadjusted odds ratios (ORs) using random-effects model. Subgroup analysis was conducted based on study design (cohort and case control). Association between hyperglycaemia in preterm neonates (<32 weeks or <1500 g) and mortality and morbidities. Forty-six studies (30 cohort and 16 case control) with data from 34 527 infants were included. Meta-analysis of unadjusted ORs from cohort studies found hyperglycaemia to be significantly associated with mortality, any-grade intraventricular haemorrhage (IVH), severe IVH, any-stage retinopathy of prematurity (ROP), severe ROP, sepsis, chronic lung disease and disability. However, pooling of adjusted ORs found significant associations only for mortality (adjusted OR (CI): 2.37 (1.40 to 4.01); I Hyperglycaemia in very preterm infants is associated with higher odds of mortality, any-grade IVH and any-stage ROP. A limitation was lack of availability of adjusted ORs from many of the included studies. CRD42020193016.
Identifiants
pubmed: 34330757
pii: archdischild-2020-321449
doi: 10.1136/archdischild-2020-321449
doi:
Types de publication
Journal Article
Meta-Analysis
Systematic Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
269-280Informations de copyright
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.